Diffuse marrow abnormality on magnetic resonance imaging secondary to pernicious anaemia
Spontaneous splenic rupture due to isolated splenic peliosis in a case of multiple myeloma
Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia
Van-den Berghe's 5q- syndrome in 2008
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma
Long-term follow-up of a population based cohort with monoclonal proteinaemia
Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene
Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia
The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment
Desmopressin responsiveness in children with Ehlers-Danlos syndrome associated bleeding symptoms
The relationship between lifestyle factors and venous thromboembolism among women
Screening and treatment for heritable thrombophilia in pregnancy failure
Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients
The prognostic significance of 8p21 deletion in multiple myeloma
The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9)
CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines